Issued Patents All Time
Showing 1–25 of 29 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 8623412 | Abuse-resistant pharmaceutical compositions | Vaghefi Farid, Stephen B. Ruddy, Eugene R. Cooper | 2014-01-07 |
| 8367112 | Nanoparticulate carverdilol formulations | Scott Jenkins | 2013-02-05 |
| 8309133 | Nanoparticulate quinazoline derivative formulations | Scott Jenkins | 2012-11-13 |
| 8293277 | Controlled-release nanoparticulate compositions | Jon Swanson, Rajeev Jain, Robert Hontz, John Devane, Kenneth Iain Cumming +2 more | 2012-10-23 |
| 8236352 | Glipizide compositions | H. William Bosch, Niels P. Ryde, Rajeev Jain, Jon Swanson, Robert Hontz +4 more | 2012-08-07 |
| 8158153 | Nanoparticulate bisphosphonate compositions | Scott Jenkins | 2012-04-17 |
| 8119163 | Nanoparticulate and controlled release compositions comprising cefditoren | John Devane, Paul Stark, Niall Fanning, Gurvinder Singh Rekhi, Scott Jenkins | 2012-02-21 |
| 8003127 | Nanoparticulate corticosteroid and antihistamine formulations methods of making, and methods of administering thereof | Scott Jenkins, H. William Bosch, Christian F. Wertz | 2011-08-23 |
| 7910577 | Injectable nanoparticulate olanzapine formulations | Scott Jenkins, Elaine Liversidge | 2011-03-22 |
| 7825087 | Nanoparticulate and controlled release compositions comprising cyclosporine | Scott Jenkins | 2010-11-02 |
| RE41884 | Reduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactions | Lawrence de Garavilla, Elaine Liversidge | 2010-10-26 |
| 7763278 | Nanoparticulate polycosanol formulations and novel polycosanol combinations | Eugene R. Cooper, Laura Kline, Niels P. Ryde | 2010-07-27 |
| 6432381 | Methods for targeting drug delivery to the upper and/or lower gastrointestinal tract | W. Mark Eickhoff, Kathleen J. Illig, Pramod Sarpotdar, Stephen B. Ruddy | 2002-08-13 |
| 6221400 | Methods of treating mammals using nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors | David A. Engers, Mary E. Roberts, Stephen B. Ruddy, Sui-Ming Wong, Shuqian Xu | 2001-04-24 |
| 6068858 | Methods of making nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers | David A. Engers, Mary E. Roberts, Stephen B. Ruddy, Sui-Ming Wong, Shuqian Xu | 2000-05-30 |
| 6045829 | Nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers | David A. Engers, Mary E. Roberts, Stephen B. Ruddy, Sui-Ming Wong, Shuqian Xu | 2000-04-04 |
| 5834025 | Reduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactions | Lawrence de Garavilla, Elaine Liversidge | 1998-11-10 |
| 5628981 | Formulations of oral gastrointestinal diagnostic x-ray contrast agents and oral gastrointestinal therapeutic agents | W. Mark Eickhoff, Kathleen J. Illig, Pramod Sarpotdar, Stephen B. Ruddy | 1997-05-13 |
| 5593657 | Barium salt formulations stabilized by non-ionic and anionic stabilizers | Stephen B. Ruddy, W. Mark Eickhoff, Mary E. Roberts | 1997-01-14 |
| 5585108 | Formulations of oral gastrointestinal therapeutic agents in combination with pharmaceutically acceptable clays | Stephen B. Ruddy, W. Mark Eickhoff, Eugene R. Cooper | 1996-12-17 |
| 5580579 | Site-specific adhesion within the GI tract using nanoparticles stabilized by high molecular weight, linear poly (ethylene oxide) polymers | Stephen B. Ruddy, W. Mark Eickhoff | 1996-12-03 |
| 5552160 | Surface modified NSAID nanoparticles | Philip Conzentino, Jr., Kenneth C. Cundy, Pramod Sarpotdar | 1996-09-03 |
| 5494683 | Surface modified anticancer nanoparticles | Elaine Liversidge, Pramod Sarpotdar | 1996-02-27 |
| 5466440 | Formulations of oral gastrointestinal diagnostic X-ray contrast agents in combination with pharmaceutically acceptable clays | Stephen B. Ruddy, W. Mark Eickhoff, Eugene R. Cooper | 1995-11-14 |
| 5451393 | X-ray contrast compositions useful in medical imaging | Eugene R. Cooper, J. Michael Shaw, Gregory L. McIntire | 1995-09-19 |